154 related articles for article (PubMed ID: 38188028)
1. Peripheral immune markers and amyotrophic lateral sclerosis: a Mendelian randomization study.
Hu Z; Zuo C; Mao C; Shi C; Xu Y
Front Neurosci; 2023; 17():1269354. PubMed ID: 38188028
[TBL] [Abstract][Full Text] [Related]
2. Natural killer cells-related immune traits and amyotrophic lateral sclerosis: A Mendelian randomization study.
Gong Z; Liu Y; Ding F; Ba L; Zhang M
Front Neurosci; 2022; 16():981371. PubMed ID: 36248644
[TBL] [Abstract][Full Text] [Related]
3. Causal Association of Leukocytes Count and Amyotrophic Lateral Sclerosis: a Mendelian Randomization Study.
Li C; Yang W; Wei Q; Shang H
Mol Neurobiol; 2020 Nov; 57(11):4622-4627. PubMed ID: 32770314
[TBL] [Abstract][Full Text] [Related]
4. Causal association of type 2 diabetes with amyotrophic lateral sclerosis: new evidence from Mendelian randomization using GWAS summary statistics.
Zeng P; Wang T; Zheng J; Zhou X
BMC Med; 2019 Dec; 17(1):225. PubMed ID: 31796040
[TBL] [Abstract][Full Text] [Related]
5. Circulating Levels of T-Cell Traits and the Risk of Amyotrophic Lateral Sclerosis: A Mendelian Randomization Study.
Lu T; Luo L; Yang J; Cheng X; Sun J
Mol Neurobiol; 2024 May; ():. PubMed ID: 38748065
[TBL] [Abstract][Full Text] [Related]
6. Associations of the circulating levels of cytokines with risk of amyotrophic lateral sclerosis: a Mendelian randomization study.
Liu B; Lyu L; Zhou W; Song J; Ye D; Mao Y; Chen GB; Sun X
BMC Med; 2023 Feb; 21(1):39. PubMed ID: 36737740
[TBL] [Abstract][Full Text] [Related]
7. Investigation of the causal relationship between ALS and autoimmune disorders: a Mendelian randomization study.
Alipour P; Senkevich K; Ross JP; Spiegelman D; Manousaki D; Dion PA; Rouleau GA
BMC Med; 2022 Nov; 20(1):382. PubMed ID: 36320012
[TBL] [Abstract][Full Text] [Related]
8. Dietary-Derived Essential Nutrients and Amyotrophic Lateral Sclerosis: A Two-Sample Mendelian Randomization Study.
Xia K; Wang Y; Zhang L; Tang L; Zhang G; Huang T; Huang N; Fan D
Nutrients; 2022 Feb; 14(5):. PubMed ID: 35267896
[TBL] [Abstract][Full Text] [Related]
9. Leukocyte telomere length and amyotrophic lateral sclerosis: a Mendelian randomization study.
Xia K; Zhang L; Zhang G; Wang Y; Huang T; Fan D
Orphanet J Rare Dis; 2021 Dec; 16(1):508. PubMed ID: 34906191
[TBL] [Abstract][Full Text] [Related]
10. Bidirectional Mendelian randomization to explore the causal relationships between Sleep traits, Parkinson's disease and Amyotrophic lateral sclerosis.
Di H; Zhu Y; Xia W; Meng X; Zhang M; Xu M; Feng J; Tian Q; He Y; Cao S; Lu Z
Sleep Med; 2022 Aug; 96():42-49. PubMed ID: 35594779
[TBL] [Abstract][Full Text] [Related]
11. Assessing the Causal Role of Selenium in Amyotrophic Lateral Sclerosis: A Mendelian Randomization Study.
He D; Cui L
Front Genet; 2021; 12():724903. PubMed ID: 34691149
[No Abstract] [Full Text] [Related]
12. Two-sample Mendelian randomization analysis of 91 circulating inflammatory protein levels and amyotrophic lateral sclerosis.
Xiao C; Gu X; Feng Y; Shen J
Front Aging Neurosci; 2024; 16():1367106. PubMed ID: 38601850
[TBL] [Abstract][Full Text] [Related]
13. Assessing the role of blood pressure in amyotrophic lateral sclerosis: a Mendelian randomization study.
Xia K; Zhang L; Tang L; Huang T; Fan D
Orphanet J Rare Dis; 2022 Feb; 17(1):56. PubMed ID: 35172853
[TBL] [Abstract][Full Text] [Related]
14. The genetic relationships between immune cell traits, circulating inflammatory proteins and preeclampsia/eclampsia.
Liu Y; Zhang Y; Du L; Chen D
Front Immunol; 2024; 15():1389843. PubMed ID: 38873604
[TBL] [Abstract][Full Text] [Related]
15. Causal effects of serum sex hormone binding protein levels on the risk of amyotrophic lateral sclerosis: a mendelian randomization study.
Ou YN; Yang L; Wu BS; Tan L; Yu JT
Ann Transl Med; 2022 Oct; 10(19):1054. PubMed ID: 36330403
[TBL] [Abstract][Full Text] [Related]
16. Serum Creatinine Protects Against Amyotrophic Lateral Sclerosis: a Mendelian Randomization Study.
Wang M; Liu D; Zhang Z; Xie W; Cao L; Zhu L; Liu M; Sheng S; Lian X
Mol Neurobiol; 2021 Jun; 58(6):2910-2915. PubMed ID: 33555548
[TBL] [Abstract][Full Text] [Related]
17. Iron Status May Not Affect Amyotrophic Lateral Sclerosis: A Mendelian Randomization Study.
Cai J; Chen X; Wang H; Wei Z; Li M; Rong X; Li X; Peng Y
Front Genet; 2021; 12():617245. PubMed ID: 33747043
[TBL] [Abstract][Full Text] [Related]
18. Association Between Premorbid Body Mass Index and Amyotrophic Lateral Sclerosis: Causal Inference Through Genetic Approaches.
Zeng P; Yu X; Xu H
Front Neurol; 2019; 10():543. PubMed ID: 31178821
[No Abstract] [Full Text] [Related]
19. Cortical structure and the risk of amyotrophic lateral sclerosis: A bidirectional Mendelian randomization study.
Jia H; Li Z; Guo F; Hua Z; Zhou X; Li X; Li R; Liu Q; Liu Y; Dong H
Prog Neuropsychopharmacol Biol Psychiatry; 2024 Feb; 129():110872. PubMed ID: 37827425
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-1 receptor antagonist, interleukin-2 receptor alpha subunit and amyotrophic lateral sclerosis.
Yuan S; Roos PM; Larsson SC
Eur J Neurol; 2020 Oct; 27(10):1913-1917. PubMed ID: 32441415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
